Oxazolo[5,4-f]quinoxaline-type selective inhibitors of glycogen synthase kinase-3α (GSK-3α): Development and impact on temozolomide treatment of glioblastoma cells

1. Hasyeoui, M.
2. Lassagne, F.
3. Erb, W.
4. Nael, M.
5. Elokely, K.M.
6. Chaikuad, A.
7. Knapp, S.
8. Jorda, A.
9. Vallés, S.L.
10. Quissac, E.
11. Verreault, M.
12. Robert, T.
13. Bach, S.
14. Samarat, A.
15. Mongin, F.